HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

OBERWEIS ASSET MANAGEMENT INC/'s Holding History (CIK: 0000937886)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 117,580 Value ($000) $7,913 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 117,580 Value ($000) $8,623 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 182,200 Value ($000) $9,478 Avg Close $56.90 Range $47.50 - $70.51
Q4 2023
Shares 96,300 Value ($000) $3,559 Avg Close $37.66 Range $32.83 - $42.82
Q3 2023
Shares 50,500 Value ($000) $1,929 Avg Close $40.96 Range $35.71 - $45.00
Q1 2023
Shares 164,040 Value ($000) $6,265 Avg Close $46.91 Range $32.83 - $57.00
Q4 2022
Shares 143,390 Value ($000) $8,159 Avg Close $51.20 Range $39.17 - $59.46
Q3 2022
Shares 116,540 Value ($000) $4,608 Avg Close $44.20 Range $38.03 - $52.98
Q2 2022
Shares 103,050 Value ($000) $4,534 Avg Close $43.25 Range $36.95 - $48.58
Q1 2022
Shares 107,450 Value ($000) $4,285 Avg Close $35.62 Range $31.36 - $42.33
Q4 2021
Shares 105,650 Value ($000) $4,248 Avg Close $37.33 Range $31.79 - $41.20
Q3 2021
Shares 69,980 Value ($000) $2,847 Avg Close $41.81 Range $37.80 - $46.62
Q2 2021
Shares 69,200 Value ($000) $3,142 Avg Close $44.26 Range $38.65 - $51.57
Q1 2021
Shares 68,900 Value ($000) $2,872 Avg Close $45.65 Range $38.80 - $56.40